NPS Pharmaceuticals to Present at BIO CEO & Investor Conference

Show Health and Fitness Publications

Wed, February 11, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

Novelos Therapeutics and Mundipharma Sign Exclusive Collaboration Agreement in Europe and Japan

[ Wed, Feb 11th 2009 ] - Market Wire

ZymoGenetics Reports Fourth Quarter and Year End 2008 Financial Results

[ Wed, Feb 11th 2009 ] - Market Wire

Zila Completes First Phase of Global Marketing In .. or Oral Cancer Screening Product, ViziLite® Plus

[ Wed, Feb 11th 2009 ] - Market Wire

Pacific Biometrics, Inc.: Pacific Biometrics to H .. r Conference Call on Wednesday, February 18, 2009

[ Wed, Feb 11th 2009 ] - Market Wire

ImmuCell Corporation: ImmuCell Announces Financial Results for 2008

[ Wed, Feb 11th 2009 ] - Market Wire

Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. nce of Claims Relating to Heat Shock Protein dnaJ

[ Wed, Feb 11th 2009 ] - Market Wire

BioElectronics Corporation: BioElectronics Announces Major Shipments

[ Wed, Feb 11th 2009 ] - Market Wire

Lpath, Inc.: Category Leader Lpath Establishes Key 2009 Goals

[ Wed, Feb 11th 2009 ] - Market Wire

Angeion to Announce 2009 First-Quarter Results on Wednesday, February 25

[ Wed, Feb 11th 2009 ] - Market Wire

Synta Pharmaceuticals to Present at the ROTH Capi .. l Partners 21st Annual OC Growth Stock Conference

[ Wed, Feb 11th 2009 ] - Market Wire

Orthofix International and The Musculoskeletal Tr .. Accelerate Release Date for Trinity® Evolution"

[ Wed, Feb 11th 2009 ] - Market Wire

Genta Submits Randomized Study of Tesetaxel in Pa .. ric Cancer to FDA for Special Protocol Assessment

[ Wed, Feb 11th 2009 ] - Market Wire

Alnylam and Collaborators Publish New Pre-Clinica .. ivo Efficacy of Systemically Delivered RNAi Thera

[ Wed, Feb 11th 2009 ] - Market Wire

Professor John F. Thompson to Present at the Sixt .. Melanoma and Other Cutaneous Malignancies on Marc

[ Wed, Feb 11th 2009 ] - Market Wire

POZEN Announces February 25, 2009 Webcast of Fourth Quarter and Year End 2008 Results

[ Wed, Feb 11th 2009 ] - Market Wire

Salix Pharmaceuticals to Present at Roth Conference

[ Wed, Feb 11th 2009 ] - Market Wire

Compugen Ltd. Reports Fourth Quarter and Year-End 2008 Financial Results

[ Wed, Feb 11th 2009 ] - Market Wire

Gilead pr©sente des donn©es montrant l?activit© d?amplification pharmacocin©tique du GS 9350

[ Wed, Feb 11th 2009 ] - Market Wire

Zacks Industry Outlook Highlights: Pfizer, Eli Lilly, Merck, Sanofi and Schering-Plough

[ Wed, Feb 11th 2009 ] - Market Wire

Micrus Endovascular Initiates VISSIT Trial with Pharos Vitesse Balloon Expandable Stent

Tue, February 10, 2009

[ Tue, Feb 10th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces Publication in The A .. oncerning Blood Volume in Critically Ill Surgical

[ Tue, Feb 10th 2009 ] - Market Wire

Significant Shareholder Calls upon Enzon to Immed .. tely Add Two Candidates to the Board of Directors

[ Tue, Feb 10th 2009 ] - Market Wire

Tenet Announces Definitive Agreement to Sell USC University Hospital

[ Tue, Feb 10th 2009 ] - Market Wire

NeuroMetrix, Inc. Reports Total Revenues of $7.2 Million for the Fourth Quarter of 2008

[ Tue, Feb 10th 2009 ] - Market Wire

Enzon Announces IND Acceptance for Its Survivin Antagonist

[ Tue, Feb 10th 2009 ] - Market Wire

Oculus Innovative Sciences to Present at the Roth .. l Partners 21st Annual OC Growth Stock Conference

[ Tue, Feb 10th 2009 ] - Market Wire

Cougar Biotechnology Announces Agreement with FDA .. nt for Phase III Trial of CB7630 (Abiraterone Ace

[ Tue, Feb 10th 2009 ] - Market Wire

PPD to Receive Milestone Payments for First Regul .. Dapoxetine) in Finland and Sweden for Treatment o

[ Tue, Feb 10th 2009 ] - Market Wire

Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics

[ Tue, Feb 10th 2009 ] - Market Wire

Quidel to Hold 2008 Fourth Quarter and Year-End F .. cial Results Conference Call on February 25, 2009

[ Tue, Feb 10th 2009 ] - Market Wire

Progenics Selects Subcutaneous Form of PRO 140, a .. vel HIV Antibody Therapy, for Further Development

[ Tue, Feb 10th 2009 ] - Market Wire

Synta Pharmaceuticals Announces First Patient Tre .. Elesclomol Monotherapy Solid Tumor Clinical Study

[ Tue, Feb 10th 2009 ] - Market Wire

Curis Reports Fourth Quarter and Year-End 2008 Financial Results

[ Tue, Feb 10th 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific, Inc. Receives a $200,000 Order for CatPro 5000 System

[ Tue, Feb 10th 2009 ] - Market Wire

Inspire Elects Alan F. Holmer to Board of Directors

[ Tue, Feb 10th 2009 ] - Market Wire

VIVUS Initiates Second Pivotal Phase 3 Trial of Avanafil for Treatment of Erectile Dysfunction

[ Tue, Feb 10th 2009 ] - Market Wire

Natus to Present at the Roth Capital Partners 21st Annual Growth Stock Conference

[ Tue, Feb 10th 2009 ] - Market Wire

Cubist Plans to Commence Patent Infringement Liti .. nteral Medicines, Inc. In Response To ANDA filing

[ Tue, Feb 10th 2009 ] - Market Wire

Dyax and Fovea Sign Development and Commercializa .. ion Agreement for DX-88 in Ophthalmic Indications

[ Tue, Feb 10th 2009 ] - Market Wire

Bioject Extends Supply Agreement with Ferring Pharmaceuticals, Inc.

Mon, February 9, 2009

[ Mon, Feb 09th 2009 ] - Market Wire

UnitedHealthcare, IBM, and Arizona Physicians to .. ndbreaking Patient-Centered Healthcare Initiative

[ Mon, Feb 09th 2009 ] - Market Wire

Clinical Data Announces Third Quarter Fiscal 2009 Financial Results

[ Mon, Feb 09th 2009 ] - Market Wire

Orthofix International Raises Concerns About Another Ramius Nominee for Orthofix Board

[ Mon, Feb 09th 2009 ] - Market Wire

Forbes Medi-Tech Inc.: Leading Healthy Lifestyle .. y Proven Benefits of Forbes Medi-Tech's Cholester

[ Mon, Feb 09th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Initiates .. nnaissance Surveys on Potash Resource in Ethiopia

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences? Security Holders Exer .. any as Result of Recently Announced Strategic Inv

[ Mon, Feb 09th 2009 ] - Market Wire

Genta Incorporated to Release Fourth Quarter Financial Results and Host Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

Curis Announces Collaborative Agreement between G .. nentech and National Cancer Institute on GDC-0449

[ Mon, Feb 09th 2009 ] - Market Wire

Synovis Life Technologies to Present at 21st Annu .. Capital Partners Growth Stock Conference Feb. 18

[ Mon, Feb 09th 2009 ] - Market Wire

Ligand Earns $1 Million Milestone Payment on Progress of Drug Candidate for Alzheimer?s Disease

[ Mon, Feb 09th 2009 ] - Market Wire

Oculus Innovative Sciences Announces Fiscal Third .. and Corporate Update Release and Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

UnitedHealth Group Awarded LEED® Green Building Certification

[ Mon, Feb 09th 2009 ] - Market Wire

Synta Pharmaceuticals Names Dr. Vojo Vukovic, Vice President, Clinical Research

[ Mon, Feb 09th 2009 ] - Market Wire

Theragenics Corporation® Announces Schedule for Fourth Quarter and Year-End 2008 Conference Call

[ Mon, Feb 09th 2009 ] - Market Wire

Compugen Appoints Dov Hershberg Chairman of the Board

[ Mon, Feb 09th 2009 ] - Market Wire

Inhibitex Completes Phase I Clinical Trials for F .. ad HCV Compounds for Advanced Preclinical Studies

[ Mon, Feb 09th 2009 ] - Market Wire

Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine

[ Mon, Feb 09th 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Issues G .. hrough to Profitability for the Full Year of 2009

[ Mon, Feb 09th 2009 ] - Market Wire

EPIX Pharmaceuticals Provides Update on NASDAQ Listing Status

[ Mon, Feb 09th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Biogen Idec, CEMEX, Ford, Tata Motors and Carmike Cinemas

Sun, February 8, 2009

[ Sun, Feb 08th 2009 ] - Market Wire

Riassunto: Nei pazienti affetti da sclerosi multi .. malattia non manifesta attivit per due anni, seco

[ Sun, Feb 08th 2009 ] - Market Wire

MS Patients Treated with TYSABRI® Remain Free of .. s, According to Data Published in the Lancet Neur

Fri, February 6, 2009

[ Fri, Feb 06th 2009 ] - Market Wire

Celgene Corporation to Present at the 11th Annual BIO CEO Investor Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Proton Laboratories Inc.: Proton Labs to Begin Bottling Functional Water

[ Fri, Feb 06th 2009 ] - Market Wire

Geron to Present at BIO CEO & Investor Conference

[ Fri, Feb 06th 2009 ] - Market Wire

MEDNAX to Present at UBS Global Healthcare Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Gilead Sciences to Present at the 11th Annual BIO CEO Investor Conference on Tuesday, February 10

[ Fri, Feb 06th 2009 ] - Market Wire

Span-America Announces Termination of Hill-Rom Supply Contract

[ Fri, Feb 06th 2009 ] - Market Wire

CIGNA Announces Appearance at the UBS Global Healthcare Services Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Odyssey Healthcare to Broadcast Its Fourth Quarte .. ear-End 2008 Conference Call Live on the Internet

[ Fri, Feb 06th 2009 ] - Market Wire

LifePoint Hospitals to Broadcast Its Fourth Quart .. ear-End 2008 Conference Call Live on the Internet

[ Fri, Feb 06th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma to Present .. l Partners 21st Annual OC Growth Stock Conference

[ Fri, Feb 06th 2009 ] - Market Wire

Advanced Medical Optics, Inc. Gives Notice of Ant .. nd Merger to Holders of Convertible Senior Subord

[ Fri, Feb 06th 2009 ] - Market Wire

Aeolus Pharmaceuticals Announces First Quarter Fiscal Year 2009 Financial Results

[ Fri, Feb 06th 2009 ] - Market Wire

Medtronic Completes Acquisition of Ablation Frontiers

[ Fri, Feb 06th 2009 ] - Market Wire

Ligand Enters into Screening Agreement with Trevena

[ Fri, Feb 06th 2009 ] - Market Wire

Biogen Idec Receives Shareholder Proposal

[ Fri, Feb 06th 2009 ] - Market Wire

Health Management Associates, Inc. Announces Four .. ear-End 2008 Earnings Conference Call and Webcast

[ Fri, Feb 06th 2009 ] - Market Wire

The Genome Center at Washington University Scales-Up on Illumina Sequencers

Thu, February 5, 2009

[ Thu, Feb 05th 2009 ] - Market Wire

Aetna Awarded $150,000 to Northern California Nonprofits in 2008

[ Thu, Feb 05th 2009 ] - Market Wire

FORTIS: Fortis publishes explanatory document on voting at General Meeting

[ Thu, Feb 05th 2009 ] - Market Wire

SCOR: Prestigious Redmayne report recognises SCOR .. d Protection reinsurance in the United Kingdom an

[ Thu, Feb 05th 2009 ] - Market Wire

Targacept to Report Fourth Quarter and 2008 Financial Results on February 12, 2009

[ Thu, Feb 05th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation Announces Fourth Quarter and Full Year 2008 Results

[ Thu, Feb 05th 2009 ] - Market Wire

Certified Diabetic Services, Inc. Terminates Asset Purchase Agreement

[ Thu, Feb 05th 2009 ] - Market Wire

BioSante Pharmaceuticals, Inc. To Present At BIO CEO and Investor Conference and ISSWSH Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Progen-Avexa Merger Notice of Meeting and Independent Expert Report

[ Thu, Feb 05th 2009 ] - Market Wire

GeneThera: GeneThera Offers Discounted Johne's Di .. ted by Government's Call to Eliminate 400,000 Hea

[ Thu, Feb 05th 2009 ] - Market Wire

Applied Biosystems Awards Genomic Research Grant to St. Jude Children?s Research Hospital

[ Thu, Feb 05th 2009 ] - Market Wire

StemCells, Inc. to Present at the 11th Annual BIO CEO & Investor Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Dr. Reddy?s Announces Five ANDA Approvals and Generic Product Launches in the US Market

[ Thu, Feb 05th 2009 ] - Market Wire

GTx, Inc. Announces Fourth Quarter and Year End 2008 Corporate Results Conference Call and Webcast

[ Thu, Feb 05th 2009 ] - Market Wire

BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B

[ Thu, Feb 05th 2009 ] - Market Wire

Cytori Patent Allowance Expands Celution® System .. n for Adipose Stem & Regenerative Cell Processing

[ Thu, Feb 05th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. he 2009 UBS Global Healthcare Services Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Myriad G .. , School Specialty, Exxon, Chevron and Transocean

[ Thu, Feb 05th 2009 ] - Market Wire

Illumina Presents Development Roadmap for Scaling its Genome Analyzer

[ Thu, Feb 05th 2009 ] - Market Wire

Exelixis Announces February 10 Webcast of Present .. at the 11th Annual BIO CEO & Investor Conference

Wed, February 4, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Sun Healthcare Group, Inc.: Sun Healthcare Group, .. ; Schedules Conference Call to Announce 2008 Earn

[ Wed, Feb 04th 2009 ] - Market Wire

Lpath, Inc.: Lpath to Provide Fourth Quarter 2008 Business Review and 2009 Plan

[ Wed, Feb 04th 2009 ] - Market Wire

Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference

[ Wed, Feb 04th 2009 ] - Market Wire

COPAXONE® is Approved for Treatment of Patients .. t Clinical Event Suggestive of Multiple Sclerosis

[ Wed, Feb 04th 2009 ] - Market Wire

Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares

[ Wed, Feb 04th 2009 ] - Market Wire

Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of

[ Wed, Feb 04th 2009 ] - Market Wire

Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry

[ Wed, Feb 04th 2009 ] - Market Wire

Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices

[ Wed, Feb 04th 2009 ] - Market Wire

Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,

[ Wed, Feb 04th 2009 ] - Market Wire

Conceptus® to Present at the ROTH 21st Annual OC Growth Stock Conference

[ Wed, Feb 04th 2009 ] - Market Wire

Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3

[ Wed, Feb 04th 2009 ] - Market Wire

Progenics Appoints Peter J. Crowley as Independent Board Member

[ Wed, Feb 04th 2009 ] - Market Wire

UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards

[ Wed, Feb 04th 2009 ] - Market Wire

EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening

[ Wed, Feb 04th 2009 ] - Market Wire

Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System

[ Wed, Feb 04th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf

[ Wed, Feb 04th 2009 ] - Market Wire

MEDNAX, Inc. Acquires Neonatal Practice

[ Wed, Feb 04th 2009 ] - Market Wire

Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures

Tue, February 3, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment

[ Tue, Feb 03rd 2009 ] - Market Wire

ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development

[ Tue, Feb 03rd 2009 ] - Market Wire

Affymax to Present at BIO CEO and Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses

[ Tue, Feb 03rd 2009 ] - Market Wire

PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM

[ Tue, Feb 03rd 2009 ] - Market Wire

Amarin to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Amedisys Acquires Two Home Health Agencies in Arizona

[ Tue, Feb 03rd 2009 ] - Market Wire

GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.

[ Tue, Feb 03rd 2009 ] - Market Wire

Inspire Announces Webcast of Presentation at BIO CEO Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement

[ Tue, Feb 03rd 2009 ] - Market Wire

Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19

Mon, February 2, 2009

[ Mon, Feb 02nd 2009 ] - Market Wire

Kindred Healthcare to Present at the UBS Global Healthcare Services Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

LHC Group and Ochsner Health System Complete Home Health Joint Venture

[ Mon, Feb 02nd 2009 ] - Market Wire

Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in

[ Mon, Feb 02nd 2009 ] - Market Wire

Ligand Announces Phase IIb Results With DARA

[ Mon, Feb 02nd 2009 ] - Market Wire

Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study

[ Mon, Feb 02nd 2009 ] - Market Wire

Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call

[ Mon, Feb 02nd 2009 ] - Market Wire

Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia

[ Mon, Feb 02nd 2009 ] - Market Wire

ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma

[ Mon, Feb 02nd 2009 ] - Market Wire

Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital

[ Mon, Feb 02nd 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)

[ Mon, Feb 02nd 2009 ] - Market Wire

Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®

[ Mon, Feb 02nd 2009 ] - Market Wire

Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment

[ Mon, Feb 02nd 2009 ] - Market Wire

Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S

[ Mon, Feb 02nd 2009 ] - Market Wire

LifePoint Hospitals Acquires Rockdale Medical Center

[ Mon, Feb 02nd 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in

[ Mon, Feb 02nd 2009 ] - Market Wire

ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results

Sun, February 1, 2009

[ Sun, Feb 01st 2009 ] - Market Wire

FORTIS: Fortis holding announcement

Sat, January 31, 2009

[ Sat, Jan 31st 2009 ] - Market Wire

FORTIS: Fortis holding publishes addendum to shareholder circular

[ Sat, Jan 31st 2009 ] - Market Wire

Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d

Fri, January 30, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification

[ Fri, Jan 30th 2009 ] - Market Wire

Teva Announces Approval of Generic Risperdal® Oral Solution

[ Fri, Jan 30th 2009 ] - Market Wire

ZOLL Announces Filing of Patent Infringement Suit .. Alsius Corporation and Alsius Medical Corporation

[ Fri, Jan 30th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer

[ Fri, Jan 30th 2009 ] - Market Wire

First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence

[ Fri, Jan 30th 2009 ] - Market Wire

DexCom Announces Pricing of Public Offering of Common Stock

[ Fri, Jan 30th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference

[ Fri, Jan 30th 2009 ] - Market Wire

GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry

[ Fri, Jan 30th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas

[ Fri, Jan 30th 2009 ] - Market Wire

Progen-Avexa Merger Update

[ Fri, Jan 30th 2009 ] - Market Wire

St. Jude Medical Announces 2009 Annual Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

SonoSite Introduces Powerful New Turbo Technology for S Series"

[ Fri, Jan 30th 2009 ] - Market Wire

GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame

[ Fri, Jan 30th 2009 ] - Market Wire

Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time

[ Fri, Jan 30th 2009 ] - Market Wire

REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us

[ Fri, Jan 30th 2009 ] - Market Wire

Santarus Submits New Drug Application for ZEGERID Tablet Product

Thu, January 29, 2009

[ Thu, Jan 29th 2009 ] - Market Wire

Universal Health Services, Inc. Announces Fourth .. ll Year 2008 Earnings Release and Conference Call

[ Thu, Jan 29th 2009 ] - Market Wire

EXACT Sciences Regains NASDAQ Compliance

[ Thu, Jan 29th 2009 ] - Market Wire

CompCare Acquires Core Corporate Consulting Group, Inc.

[ Thu, Jan 29th 2009 ] - Market Wire

DUSA Pharmaceuticals, Inc.: DUSA Elects Alexander Casdin to Board of Directors

[ Thu, Jan 29th 2009 ] - Market Wire

Synergetics USA, Inc. Appoints David M. Hable as President & Chief Executive Officer

[ Thu, Jan 29th 2009 ] - Market Wire

Fraunhofer USA to use iBioPharma?s Technology for Pandemic Flu Vaccine Research

[ Thu, Jan 29th 2009 ] - Market Wire

BioSphere Medical Schedules Fourth Quarter 2008 Financial Results Conference Call February 12

[ Thu, Jan 29th 2009 ] - Market Wire

Harte Gold Corp.: Harte Clarifies Affairs

[ Thu, Jan 29th 2009 ] - Market Wire

Somatic Systems, Inc.: Somatic Systems, Inc. Television Show to Air in Chicago

[ Thu, Jan 29th 2009 ] - Market Wire

Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5

[ Thu, Jan 29th 2009 ] - Market Wire

Oscient Pharmaceuticals Extends Maturity of its Privately Placed 5% Convertible Promissory Notes

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $590,000 to Non-Profits in Pennsylvania

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $125,000 to North Carolina Non-Profits

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $725,000 to Georgia Non-Profits

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $857,500 to Non-Profits in Florida

[ Thu, Jan 29th 2009 ] - Market Wire

Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria

[ Thu, Jan 29th 2009 ] - Market Wire

Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete

[ Thu, Jan 29th 2009 ] - Market Wire

Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009

[ Thu, Jan 29th 2009 ] - Market Wire

Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program

NPS Pharmaceuticals to Present at BIO CEO & Investor Conference

_{//health-fitness.news-articles.net/content/2009/ .. s-to-present-at-bio-ceo-investor-conference.html}
^{Published in Health and Fitness on Wednesday, February 4th 2009 at 13:33 GMT, Last Modified on 2009-02-04 13:33:51 by Market Wire}

BEDMINSTER, N.J.--([ BUSINESS WIRE ])--NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that Francois Nader, M.D., president and chief executive officer, is scheduled to present at the 11^th Annual BIO CEO and Investor Conference in New York on Tuesday, February 10, 2009 at 11:30 a.m. ET. The presentation will be available as a live webcast with a replay available approximately three hours after the presentation has concluded. Interested parties may access the webcast from the NPS website at [ http://www.npsp.com ].

About NPS Pharmaceuticals

NPS Pharmaceuticals is developing therapeutics for rare gastrointestinal and endocrine disorders with high-unmet medical needs. The company is currently advancing two late-stage programs. Teduglutide, a proprietary analog of glucagon-like peptide-2, is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome as GATTEX™ and in preclinical development for additional intestinal failure related conditions. NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) is in Phase 3 clinical development as a hormone therapy for hypoparathyroidism. NPS complements its proprietary programs with a royalty-based portfolio of products and product candidates that includes agreements with Amgen, GlaxoSmithKline, Kyowa Kirin, Ortho-McNeil, and Nycomed. Additional information is available at [ http://www.npsp.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Mon, Feb 02nd 2009 ] - Market Wire

CytRx Corporation to Present at the 11th Annual BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Genta Incorporated to Present at the 11th Annual BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Vivus to Present at the 11th Annual BIO CEO & Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference

[ Mon, Jan 12th 2009 ] - Market Wire

Bristol-Myers Squibb and ZymoGenetics Enter Global Collaboration on Novel Hepatitis C Compound

[ Wed, Jan 07th 2009 ] - Market Wire

Facet Biotech: Facet Biotech Announces Restructur .. ng and Provides Estimate of 2009 Cash Utilization

[ Tue, Dec 30th 2008 ] - Market Wire

Publication in Journal of Medicinal Chemistry Hig .. rmaceuticals Program for Targeting Prostate Cance

[ Mon, Dec 22nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA '444 in the Treatment of COPD in the Horizon D

[ Mon, Dec 22nd 2008 ] - Market Wire

NPS Pharmaceuticals Initiates Phase 3 'REPLACE' Study of NPSP558 in Hypoparathyroidism

[ Mon, Dec 08th 2008 ] - Market Wire

Ligand Presents Positive LGD-4665 Clinical Trial .. theAmerican Society of Hematology Annual Meeting

[ Tue, Dec 02nd 2008 ] - Market Wire

Theravance, Inc.: GSK and Theravance Announce Pos .. BA, '444 in the Horizon Asthma Development Progra

[ Tue, Dec 02nd 2008 ] - Market Wire

NPS Pharmaceuticals Initiates Phase 3 STEPS Stu .. educes Parenteral Nutrition Dependence in Short B